Understanding risk of hyperkalemia in heart failure
Video navigation menu
- Potassium homeostasis and definition of hyperkalemia 04:36
- Causes of hyperkalemia 05:37
- Incidence and risk markers for hyperkalemia in HF 09:06
- Hyperkalemia is associated with increased mortality in HF 11:47
- Risk of CV death due to hyperkalemia is not statistically significant after adjusting for RAASi discontinuation 13:46
- Recommendations for managing hyperkalemia 15:30
This lecture by Piotr Ponikowski, MD, PhD was part of the EBAC-accredited symposium "Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control" held during the virtual ESC Congress 2020.
Piotr Ponikowski, MD PHD, FESC, FHFA is the professor of cardiology, Acting Rector, Vice-Rector for Scientific Affairs and the Head of Department of Heart Diseases at Wroclaw Medical University, Poland. He is also the Head of the Centre for Heart Diseases at University Hospital, Wroclaw, Poland.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Vifor.